Volume 37 Issue 4
Jul.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2021  >  37(4): 602-608
WU Qin-hang, ZHU Li-wen, LI Ming-xuan, CAO Jing, PAN Yang. Research Progress of Traditional Chinese Medicine against Triple Negative Breast Cancer and the Underlying Molecular Mechanism[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(4): 602-608. doi: 10.14148/j.issn.1672-0482.2021.0602
Citation: WU Qin-hang, ZHU Li-wen, LI Ming-xuan, CAO Jing, PAN Yang. Research Progress of Traditional Chinese Medicine against Triple Negative Breast Cancer and the Underlying Molecular Mechanism[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(4): 602-608. doi: 10.14148/j.issn.1672-0482.2021.0602
shu

Research Progress of Traditional Chinese Medicine against Triple Negative Breast Cancer and the Underlying Molecular Mechanism

doi: 10.14148/j.issn.1672-0482.2021.0602

  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China

  • Received Date: 2021-03-05
    Available Online: 2021-12-21
  • Publish Date: 2021-07-10
    Abstract
  • Triple negative breast cancer is an invasive subtype of breast cancer with high recurrence and metastasis rates, it threatens women's health seriously. Due to the lack of molecular targets, chemotherapy is still the main curing method. However, the clinical cure rate is very low. Studies have shown that traditional Chinese medicines could prevent triple negative breast cancer proliferation and reduce its metastasis obviously by multiple pathways and targets. Combined with the latest research results, the activities and mechanisms of traditional Chinese medicine active ingredients are reviewed, providing references for the development and clinical application of new Chinese medicines against triple negative breast cancer.

     

    • FullText(HTML)
  • loading
    • References(53)
  • [1]
    BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
    [2]
    MILIOLI HH, TISHCHENKO I, RIVEROS C, et al. Basal-like breast cancer: Molecular profiles, clinical features and survival outcomes[J]. BMC Med Genomics, 2017, 10(1): 19. doi: 10.1186/s12920-017-0250-9
    [3]
    HU Z, FAN C, OH DS, et al. The molecular portraits of breast tumors are conserved across microarray platforms[J]. BMC Genomics, 2006, 7: 96. doi: 10.1186/1471-2164-7-96
    [4]
    ZENG Z, CHEN X, ZHU D, et al. Low expression of circulating MicroRNA-34c is associated with poor prognosis in triple-negative breast cancer[J]. Yonsei Med J, 2017, 58(4): 697-702. doi: 10.3349/ymj.2017.58.4.697
    [5]
    SHIMELIS H, LADUCA H, HU C, et al. Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing[J]. J Natl Cancer Inst, 2018, 110(8): 855-862. doi: 10.1093/jnci/djy106
    [6]
    HURLEY J, REIS IM, RODGERS SE, et al. The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: Retrospective analysis of 144 patients[J]. Breast Cancer Res Treat, 2013, 138(3): 783-794. doi: 10.1007/s10549-013-2497-y
    [7]
    GOTO W, KASHIWAGI S, TAKADA K, et al. Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy[J]. J Transl Med, 2018, 16(1): 307. doi: 10.1186/s12967-018-1679-0
    [8]
    李云祥, 梁引库, 高飞雄, 等. 中药治疗乳腺癌疾病研究进展[J]. 中国实验方剂学杂志, 2019, 25(3): 211-219. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201903032.htm
    [9]
    CRAGG GM, NEWMAN DJ. Plants as a source of anti-cancer agents[J]. J Ethnopharmacol, 2005, 100(1/2): 72-79. http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.335.8151
    [10]
    吴沁航, 鲍刚, 朱丽文, 等. 蓝萼甲素通过PI3K/Akt信号通路诱导三阴性乳腺癌MDA-MB-231细胞凋亡[J]. 中国药理学通报, 2020, 36(9): 1227-1232. doi: 10.3969/j.issn.1001-1978.2020.09.009
    [11]
    YANG MY, WANG CJ, CHEN NF, et al. Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3[J]. Chem Biol Interact, 2014, 213: 60-68. doi: 10.1016/j.cbi.2014.02.002
    [12]
    赛娜, 周防震. 二氢杨梅素对MDA-MB-231人乳腺癌细胞端粒酶活性的影响[J]. 湖北民族学院学报(医学版), 2013, 30(4): 19-21, 25. https://www.cnki.com.cn/Article/CJFDTOTAL-FBMZ201304008.htm
    [13]
    吴腾飞, 董婉维, 王熙悦, 等. 川芎嗪通过调控PI3K/Akt信号通路抑制三阴乳腺癌的增殖侵袭和EMT[J]. 解剖科学进展, 2020, 26(3): 295-298. https://www.cnki.com.cn/Article/CJFDTOTAL-JPKX202003014.htm
    [14]
    方瑞, 赵晶晶, 盛飞凤, 等. 薯蓣皂苷激活p38MAPK/FOXO3a信号抑制三阴性乳腺癌细胞上皮-间质转化及侵袭[J]. 中国细胞生物学学报, 2018, 40(5): 640-647. https://www.cnki.com.cn/Article/CJFDTOTAL-XBZZ201805002.htm
    [15]
    FITTONJH, STRINGER DN, KARPINIEC SS. Therapies from fucoidan: An update[J]. Mar Drugs, 2015, 13(9): 5920-5946. doi: 10.3390/md13095920
    [16]
    王风仙, 叶诗华, 赵卓佳, 等. 白皮杉醇对三阴性乳腺癌细胞系MDA-MB-468抗肿瘤作用及机制[J]. 中国实验方剂学杂志, 2021, 27(7): 42-48. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202107006.htm
    [17]
    魏业东. 大黄素通过Wnt/β-catenin信号通路抑制三阴性乳腺癌转移及EMT效应的体外研究[D]. 上海: 华东理工大学, 2018.
    [18]
    JIANG K, LU Q, LI Q, et al. Astragaloside Ⅳ inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling[J]. Int Immunopharmacol, 2017, 42: 195-202. doi: 10.1016/j.intimp.2016.10.001
    [19]
    KANG DY, SP N, KIM DH, et al. Salidroside inhibits migration, invasion and angiogenesis of MDA-MB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2[J]. Int J Oncol, 2018, 53(2): 877-885. doi: 10.3892/ijo.2018.4430/download
    [20]
    何振辉, 何太平, 翁闪凡, 等. 芦荟大黄素对高转移乳腺癌细胞MDA-MB-231体外转移潜能的影响[J]. 中国药理学通报, 2013, 29(8): 1114-1118. doi: 10.3969/j.issn.1001-1978.2013.08.017
    [21]
    李伯和, 袁磊. 辣椒碱对乳腺癌MDA-MB-231细胞迁移和侵袭的抑制作用及其机制[J]. 生理学报, 2017, 69(2): 183-188. https://www.cnki.com.cn/Article/CJFDTOTAL-SLXU201702008.htm
    [22]
    CHANG HT, CHOU CT, LIN YS, et al. Esculetin, a natural coumarin compound, evokes Ca2+ movement and activation of Ca2+-associated mitochondrial apoptotic pathways that involved cell cycle arrest in ZR-75-1 human breast cancer cells[J]. Tumor Biol, 2016, 37(4): 4665-4678. doi: 10.1007/s13277-015-4286-1
    [23]
    CHEN W, WANG H, CHENG M, et al. Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling[J]. Biomed Pharmacother, 2018, 103: 435-442. doi: 10.1016/j.biopha.2018.04.076
    [24]
    MESSEHA SS, ZARMOUH NO, MENDONCA P, et al. The inhibitory effects of plumbagin on the NF-κB pathway and CCL2 release in racially different triple-negative breast cancer cells[J]. PLoS ONE, 2018, 13(7): e0201116. doi: 10.1371/journal.pone.0201116
    [25]
    DOU JW, SHANG RG, LEI XQ, et al. Total saponins of Bolbostemma paniculatum (maxim. ) Franquet exert antitumor activity against MDA-MB-231 human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway[J]. BMC Complementary Altern Med, 2019, 19(1): 1-9. doi: 10.1186/s12906-018-2420-5
    [26]
    HE Q, XUESY, TAN YQ, et al. Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer[J]. Cancer Lett, 2019, 448: 94-104. doi: 10.1016/j.canlet.2019.02.004
    [27]
    LI YL, TIAN X, LIU XD, et al. Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways[J]. Carcinogenesis, 2018, 39(5): 700-707. doi: 10.1093/carcin/bgy039
    [28]
    DUFFY C, SOROLLA A, WANG E, et al. Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer[J]. NPJ Precis Oncol, 2020, 4: 24. doi: 10.1038/s41698-020-00129-0
    [29]
    XU G, ZHAO H, XU J, et al. Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2+ breast cancer cells by attenuating nuclear factor-κB signaling[J]. J Ethnopharmacol, 2021, 269: 113705. doi: 10.1016/j.jep.2020.113705
    [30]
    HAN XH, WANG CL, XIE Y, et al. Anti-metastatic effect and mechanisms of Wenshen Zhuanggu Formula in human breast cancer cells[J]. J Ethnopharmacol, 2015, 162: 39-46. doi: 10.1016/j.jep.2014.12.036
    [31]
    GUOY, FAN Y, PEI X. Fangjihuangqi Decoction inhibits MDA-MB-231 cell invasion in vitro and decreases tumor growth and metastasis in triple-negative breast cancer xenografts tumor zebrafish model[J]. Cancer Med, 2020, 9(7): 2564-2578. doi: 10.1002/cam4.2894
    [32]
    ZHENG WX, HAN SY, JIANG ST, et al. Antitumor effects of Xi Huang pills on MDA-MB-231 cells in vitro and in vivo[J]. Mol Med Report, 2018, 18(2): 2068-2078. http://www.ingentaconnect.com/content/sp/mmr/2018/00000018/00000002/art00102
    [33]
    刘敏, 刘春亮, 梁国强, 等. 追毒方逆转三阴性乳腺癌MDA-MB-231细胞耐药的作用机制[J]. 南京中医药大学学报, 2019, 35(1): 63-67. http://xb.njucm.edu.cn/jnutcmns/ch/reader/view_abstract.aspx?file_no=zr20190115&flag=1
    [34]
    ZHENG LX, ZHENG Q, YU ZP, et al. Liuwei Dihuang pill suppresses metastasis by regulating the wnt pathway and disrupting -catenin/T cell factor interactions in a murine model of triple-negative breast cancer[J]. J Tradit Chin Med, 2019, 39(6): 826-832.
    [35]
    朱激扬, 陈华, 徐燕芳, 等. 小檗胺联合拉帕替尼对三阴性乳腺癌细胞增殖和凋亡的影响[J]. 中国医药导报, 2020, 17(20): 123-126. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202020031.htm
    [36]
    CAI Y, ZHAO B, LIANG Q, et al. The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase Ⅱα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells[J]. Eur J Pharmacol, 2017, 809: 87-97. doi: 10.1016/j.ejphar.2017.05.026
    [37]
    YUAN Z, JIANG H, ZHU X, et al. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer[J]. Biomed Pharmacother, 2017, 89: 227-232. doi: 10.1016/j.biopha.2017.02.038
    [38]
    ISLAM SS, AL-SHARIF I, SULTAN A, et al. Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway[J]. Mol Carcinog, 2018, 57(3): 333-346. doi: 10.1002/mc.22758
    [39]
    CHEN WC, LAI YA, LIN YC, et al. Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast cancer cells[J]. J Agric Food Chem, 2013, 61(48): 11817-11824. doi: 10.1021/jf404092f
    [40]
    亓子豪, 孟娇, 王子良, 等. 树舌灵芝提取物对三阴乳腺癌模型小鼠肿瘤抑制作用及其机理研究[J]. 中国中西医结合杂志, 2016, 36(3): 366-369. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201603026.htm
    [41]
    SHAY JW. Role of telomeres and telomerase in aging and cancer[J]. Cancer Discov, 2016, 6(6): 584-593. doi: 10.1158/2159-8290.CD-16-0062
    [42]
    WANG S, YAN WW, HE M, et al. Aloe emodin inhibits telomerase activity in breast cancer cells: Transcriptional and enzymological mechanism[J]. Pharmacol Rep, 2020, 72(5): 1383-1396. doi: 10.1007/s43440-020-00062-w
    [43]
    BIDET K. New insights into the implication of epigenetic alterations in the EMT of triple negative breast cancer[J]. Cancers, 2019, 11(4): 559. doi: 10.3390/cancers11040559
    [44]
    吴群丹. PI3K-Akt-mTOR信号传导通路与乳腺癌关系的研究进展[J]. 海峡药学, 2020, 32(1): 172-174. doi: 10.3969/j.issn.1006-3765.2020.01.069
    [45]
    HE X, WANG Y, ZHU J, et al. Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling[J]. Cancer Lett, 2011, 301(2): 168-176. doi: 10.1016/j.canlet.2010.11.012
    [46]
    TAN J, YU Q. Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy[J]. Chin J Cancer, 2013, 32(7): 376-379. doi: 10.5732/cjc.012.10287
    [47]
    YUE JC, LOPEZ JM. Understanding MAPK signaling pathways in apoptosis[J]. Int J Mol Sci, 2020, 21(7): 2346. doi: 10.3390/ijms21072346
    [48]
    GU XD, XU LL, ZHAO H, et al. Cantharidin suppressed breast cancer MDA-MB-231 cell growth and migration by inhibiting MAPK signaling pathway[J]. Braz J Med Biol Res, 2017, 50(7): e5920. doi: 10.1590/1414-431x20175920
    [49]
    SHIELDS BJ, WIEDE F, GURZOV EN, et al. TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers[J]. Mol Cell Biol, 2013, 33(3): 557-570. doi: 10.1128/MCB.01016-12
    [50]
    ALSAMRI H, EL HASASNA H, AL DHAHERI Y, et al. Carnosol, a natural polyphenol, inhibits migration, metastasis, and tumor growth of breast cancer via a ROS-dependent proteasome degradation of STAT3[J]. Front Oncol, 2019, 9: 743. doi: 10.3389/fonc.2019.00743
    [51]
    DEMIRCIOGLU F, WANG J, CANDIDO J, et al. Cancer associated fibroblast FAK regulates malignant cell metabolism[J]. Nat Commun, 2020, 11(1): 1290. doi: 10.1038/s41467-020-15104-3
    [52]
    乐韵, 张夏炎, 李凯. 秦皮乙素通过HIF-1α调控乏氧微环境中三阴性乳腺癌细胞干性[J]. 中国新药与临床杂志, 2020, 39(9): 558-563. https://www.cnki.com.cn/Article/CJFDTOTAL-XYYL202009012.htm
    [53]
    张宗城, 张艳玲, 叶桦, 等. 槐耳水提取物对三阴性乳腺癌干细胞特性的影响[J]. 中医药导报, 2020, 26(9): 12-14. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB202009003.htm
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (386) PDF downloads(185) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return